The Diksha Polymers IPO is a closed SME Fixed Price offer (Fresh capital only) that opened on 17 June 2026. The Diksha Polymers IPO closed on 19 June 2026, with an issue price of ₹112 per share. The Diksha Polymers IPO has a face value of ₹10 and a lot size of 1,200 shares. The Diksha Polymers IPO is listed on 24 June 2026. The Diksha Polymers IPO allotment was scheduled for 22 June 2026.
On the financial front, the Diksha Polymers IPO reported revenue of ₹51 crore for 31 Mar 2026, compared with ₹43 crore for 31 Mar 2025. The Diksha Polymers IPO PAT was ₹4 crore against ₹3 crore. The Diksha Polymers IPO EBITDA stood at ₹7 crore with a 14.27% margin. The Diksha Polymers IPO net worth as of 31 Mar 2026 was ₹9 crore.
Always verify The Diksha Polymers IPO details and GMP data with the official offer document before investing in the Diksha Polymers IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
28
26
7
Revenue
51
43
20
PAT
4
3
1
EBITDA
7
5
2
Net Worth
9
4
2
Reserves
5
4
1
Total Borrowing
15
13
4
Diksha Polymers IPO Financials FAQs
Revenue of Diksha Polymers (Amount in ₹ Crore) — 31 Mar 2026: 51; 31 Mar 2025: 43; 31 Mar 2024: 20. Profit after tax (PAT) — 31 Mar 2026: 4; 31 Mar 2025: 3; 31 Mar 2024: 1.
EBITDA of Diksha Polymers (Amount in ₹ Crore) — 31 Mar 2026: 7; 31 Mar 2025: 5; 31 Mar 2024: 2. The EBITDA margin is 14.27%.
Total assets — 31 Mar 2026: 28; 31 Mar 2025: 26; 31 Mar 2024: 7. Net worth — 31 Mar 2026: 9; 31 Mar 2025: 4; 31 Mar 2024: 2. Reserves & surplus — 31 Mar 2026: 5; 31 Mar 2025: 4; 31 Mar 2024: 1. (Amount in ₹ Crore)
Total borrowing of Diksha Polymers (Amount in ₹ Crore) — 31 Mar 2026: 15; 31 Mar 2025: 13; 31 Mar 2024: 4. Debt-to-equity ratio: 1.77.
The financials shown for Diksha Polymers IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
